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POCUS vs CTPA and PE  




Background: Pulmonary embolism (PE) is a serious and potentially life-threatening complication 
of venous thromboembolism and its diagnosis remains a challenge.  The current gold standard to 
confirm diagnosis of PE is multi-row computed tomography pulmonary angiography (CTPA) but 
has limitations and alternative imaging modalities are being investigated.  Point-of-care 
ultrasound (POCUS) has been applied in the diagnostic process in PE but whether it can safely 
replace the gold standard is of question. 
 
Methods: A literature review was conducted to evaluate the sensitivity of single versus 
multiorgan point-of-care ultrasound (POCUS) compared to CTPA in detecting PE in adult 
patients. 
Discussion: Several prospective observational studies exist investigating the use of single and 
multiorgan POCUS but are inconsistent in the selection of subjects, diagnostic reference tests 
used for comparison, criteria for PE diagnosis on POCUS and combinations of multiorgan 
POCUS used.  A limited number of studies exist for each of the combinations of multiorgan 
POCUS investigated. 
 
Conclusion: Both single organ and multiorgan POCUS have shown inferior sensitivity to CTPA 
and cannot replace this diagnostic gold standard for PE. Triple multiorgan POCUS (lung, cardiac 
and vascular) has shown the most promise thus far (sensitivity of 90%, specificity of 86%) and is 
recommended for patients that cannot receive CTPA and an adjunct to help provide alternative 
cardiopulmonary diagnoses, potentially reducing unnecessary radiographic imaging and may 
help to improve the prediction rules in stratifying risk for patients clinical suspicion of PE.  More 
consistent research is needed to clarify the role and validity of POCUS in PE. 
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INTRODUCTION 
Pulmonary embolism (PE) is the most serious and potentially life-threatening 
complication of venous thromboembolism (VTE). Pulmonary embolism requires prompt 
diagnosis and treatment to prevent fatal sequalae.  It is estimated that PE causes more than 
50,000 deaths annually, has been reported to be the third leading cause of death in hospitalized 
patients and the second most common cause of unexpected death in outpatients.1,2  In patients 
with fatal emboli, less than ten percent received appropriate treatment as the PE went 
undiagnosed antemortem. When early diagnosis of PE is achieved, and anticoagulation therapy is 
initiated immediately, it is highly effective with generally a favorable outcome; however, overall 
prognosis can be variable depending on existing underlying conditions.1,3  
Pulmonary embolism may be lethal due to its various cardiopulmonary effects.  
Obstruction of the pulmonary circulation can lead to infarction and hypoxemia due to necrosis of 
lung parenchyma, atelectasis from surfactant depletion, decreased cardiac output, increased dead 
space; bronchoconstriction may lead to wheezing and increased word of breathing.1,2 
Additionally, massive thrombus may cause hemodynamic instability and right ventricular 
failure.1  
The most common cause of PE is VTE that originate in the deep veins of the lower 
extremities and migrate to the pulmonary circulation.  The signs and symptoms of PE can vary 
depending on the size and location of the clot.  In patients with proximal deep vein thrombosis 
(DVT), approximately 50% will subsequently developed PE with most of these embolic events 
being asymptomatic; alternatively, in those with symptomatic PE, up to 70% also had DVT upon 
evaluation.1  Since both PE and DVT result from the same disease process, they are often 
evaluated in tandem and share the same risk factors.   
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Given the pathophysiology of VTE (including both DVT and PE), the signs and 
symptoms of PE can be variable in presentation and severity which contribute to the difficulty in 
making a timely and accurate diagnosis.  According to the Prospective Investigation of 
Pulmonary Embolism Diagnosis (PIOPED) study, patients with diagnosed PE most commonly 
reported signs and symptoms of dyspnea, pleuritic chest pain or tachypnea; however, other 
findings may include cough, leg pain and/or a positive Homan’s sign, hemoptysis, palpitations, 
wheezing, angina, tachycardia, temperature, rales, third or fourth heart sound, accentuated S2 
heart sound, pleural friction rub and cyanosis.1 The variation in clinical presentation of PE 
remains a main factor in missed PE diagnosis and requires clinicians to maintain a high index of 
suspicion for PE to ensure that it remains in their broad cardiopulmonary differential and work 
up.1,3,4 
Another factor complicating evaluation of PE is that it cannot rely on one diagnostic test.  
Current guidelines recommend a strategy that includes a combination of clinical assessment as 
well as laboratory and imaging studies for diagnosis.  A definitive diagnosis of PE requires 
imaging, but the use of clinical probability assessment tools combined with a D-dimer blood test 
help to determine if imaging should be pursued.2,3,5  Currently, the reference imaging test to 
initially diagnosis PE is computed tomography pulmonary angiography (CTPA) which has 
demonstrated a sensitivity of 96-100% and a specificity of 97-98%.3-6  However, despite the 
increased use and availability of CTPA, the mortality of PE has not significantly improved.2,5   
Furthermore, CTPA has limitations and cannot be used in every patient case.5,6  Given the 
drawbacks to CTPA, alternative diagnostic strategies for PE have been explored. 
The use of bedside or point-of-care ultrasound (POCUS) to aid in diagnosis of PE has 
been described as early as the mid-1960s.7 In these early, small studies, the use of lung 
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ultrasound at the bedside may have accurately diagnosed PE lesions in greater than 90% of 
cases.4,7 A similar study repeated around 1990 validated these results also reporting a diagnostic 
accuracy of 90%.8  However, the routine use of POCUS was likely not employed at the time due 
to the lack of large, prospective trials. With more recent improvements in ultrasound technology 
over the last approximately 20 years, ultrasound has been increasingly used by practitioners, 
other than radiologists and certified sonographers, in various diagnostic and procedural aspects 
of patient care.  Clinical locations in which POCUS has been more commonly utilized are those 
that rely on succinct and timely diagnosis of acute presentations – such as the emergency 
department, acute care units and the perioperative setting.9   
Given the complexity and time sensitivity factors in diagnosing PE as well as the 
emergence in use and availability of POCUS, it is logical to question if the sensitivity of POCUS 
now could rival that of CTPA to help assist in early detection of PE in adult patients presenting 
with clinical suspicion of the disease.  In order to explore this question, the initial objectives will 
be to review the current recommendations and limitations for diagnostic management of PE, 
what POCUS is as well as how it is currently is utilized to evaluate acute pulmonary pathology.  
Secondly, a review of the current literature on how POCUS compares to CTPA for diagnostic 
accuracy will be explored. 
BACKGROUND 
Challenges in Diagnostic Management of PE 
 Given the complexity in diagnosing PE but need for efficient and systematic evaluation, 
algorithms have been developed to help standardize the work up for this disease (see Figure 1 for 
an example of such an algorithm).  The initial evaluation in proposed algorithms often begin with 
a clinical assessment to help determine the probability of PE and decrease the amount of 
POCUS vs CTPA and PE  
  7 
 
unnecessary and imaging.  As previously discussed, signs and symptoms alone can be non-
specific to PE; however, when combined with other risk factors or symptoms or included in 
prediction rules, the risk stratification for true PE incidence can be better estimated.  The most 
widely used prediction rules are the Wells and Geneva rules (see Table 1).  Meta-analyses have 
validated the use of both tools as well as reported their diagnostic performance to be 
comparable.10 Some criticism has been made that items for these scoring systems may subjective 
rather than objective (e.g., “alternative diagnosis less likely than PE” or “clinical signs of DVT” 
criteria in Wells score) leading to increased additional and unnecessary diagnostic testing.11 
If a patient is determined to have an increased probability based on initial clinical 
assessment, the next test in diagnostic PE algorithms is usually to obtain a D-dimer blood test.  
Plasma D-dimer is a product of the degradation of cross-linked fibrin by plasmin and typically 
increases in the presence of thrombus. 1,3,10 The D-dimer test is used as a test of exclusion given it 
has high sensitivity but cannot be used solely for diagnostic purposes with a lower specificity. 
One of the most commonly used D-dimer tests is the rapid quantitative enzyme-linked 
immunosorbent assay (ELISA).  D-dimer ELISA levels of 300-500 mcg/L have shown to have a 
sensitivity of 95% with a specificity of 40-45%.1,3,10 Given D-dimer results do not have 100% 
sensitivity and low specificity, their use should be reserved for those patients with non-high 
probability risk to rule out PE. 
The lower specificity of D-dimer in relation to PE diagnosis can be attributed to its 
elevated presence in other conditions such as cancer, inflammation, infection, chronic kidney 
failure, pregnancy, trauma, postoperatively, previous VTE, and advancing age.  Given the 
number of elderly patients that may experience VTE, an alternative age-adjusted D-dimer cutoff 
calculation was developed for patients over the age of 50 (multiply the age of a patient by 10) 
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while the recommendation is to continue to use the limit of 500 mcg/L for patients younger than 
50 years.  The age-adjusted D-dimer cutoff has been shown to have a five-fold increase over the 
conventional cutoff ranges and is now part of the American College of Physicians Best Practice 
Advice to include in the evaluation of patients with suspected PE.  Currently, no other proposed 
and validated adjusted cutoff values exist for other conditions that affect D-dimer levels in 
patients prone to VTE (e.g., pregnancy).  The use of D-dimer should only be used in conjunction 
with an unlikely or low clinical probability assessment; if used in these cases and a positive 
result occurs, the clinician should be prepared to pursue appropriate diagnostic imaging.  The use 
of D-dimer is redundant in those with high probability assessment of PE.3,10 
Historically, the gold standard for confirmation of PE after a positive D-dimer result or 
high clinical suspicion was to then obtain imaging with pulmonary angiography (PA).  This 
method is invasive as it requires right heart catheterization and contrast injection and is usually 
less available given it requires expertise to complete.3 Alternatively, a diagnostic test that has 
been historically used in the evaluation of PE is ventilation-perfusion lung scintigraphy 
(commonly referred to as a V/Q scan).  A V/Q scan indirectly diagnoses a PE by identifying 
areas where there is a mismatch in the perfusion and ventilation of lung tissue.10  However, in 
clinical trials, a drawback to V/Q scans is that it has been shown to have high number of 
inconclusive results when compared to other more recent diagnostic imaging modalities such as 
CTPA. 3,10,12    
 The additional use of venous ultrasonography, also referred to as compression ultrasound 
(CUS), is yet another first-line test employed in the evaluation of PE.  Given the previously 
described association between DVT and PE, the presence of lower extremity DVT must be 
evaluated when PE is suspected.   Proximal lower extremity DVTs more often are associated 
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with PE and the inability to compress the common femoral veins, popliteal veins or both is 
diagnostic for a first episode of proximal DVT.  This test has been reported to have a sensitivity 
of 94% and specificity of 98% for proximal DVT evaluation but is less accurate in distal, 
recurrent or asymptomatic thrombi.1,3 A positive lower extremity CUS test supports making a 
diagnosis of PE without pursuing further imaging, and initiating early anticoagulation therapy.10    
However, not all patients with PE have DVT and this test cannot be used to exclude a diagnosis 
of PE. 
With the development and availability of CTPA around the 1990s, this modality has 
replaced PA and V/Q scanning and become the initial gold standard test to diagnose PE.3,10 The 
modality of CTPA requires injection of iodinated contrast medium in order to produce direct 
visualization of pulmonary arteries.  As CTPA technology has evolved from a single to multi-
detector row technique, so has its diagnostic accuracy with multi-row imaging (at least four-row) 
now demonstrating a sensitivity of 96-100% and specificity of 97-98%.2,3  The use of multi-
detector row CTPA as a single imaging test to safely diagnose or rule out PE has been 
established by multiple prospective outcome studies. 3,10 Furthermore, in those cases in which 
CTPA can rule out PE, this imaging modality has been shown to have the added benefit of 
providing an alternative diagnose for the underly cause of symptoms.1,3 
Several limitations for the use of CTPA exist.  Although this imaging modality has been 
shown to have both high sensitivity and specificity, there is still potential for false-negative 
results in those patients evaluated to have high clinical probability.3 It has also been reported that 
CTPA is the most sensitive for detecting proximal (central) PE but may be less sensitive for 
detecting peripheral (distal) PE.3  Furthermore, CTPA is contraindicated for those patients who 
have significantly impaired renal function or are pregnant.3,12  In patients with mild to moderate 
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allergy to contrast media, CTPA is relatively contraindicated but may still be pursued if patients 
are pre-medicated with a regimen of corticosteroids with or without histamines.13  Another 
disadvantage of CTPA is the radiation exposure which has been reported to range from three to 
five millisieverts (mSv), equating to an estimated risk of 450-750 excess cancer deaths per 
million exposed to a single CTPA for suspected PE.3 This imaging modality also requires the 
patient to be stable enough to be transported to the radiology department and requires specialized 
staff to perform which may not always be available at all institutions.3   
With the increased utilization of CTPA, an increase in PE diagnosis has been observed 
but without a corresponding decrease to mortality.2,5,6  Furthermore, the number of patients 
receiving CTPA with negative results has significantly increased indicating that a number of 
patients are put at increased risk receiving unnecessarily increased radiation exposure and subject 
to side effects of contrast media.6  One theory to explain this observation is that with the 
availability of CTPA, there may be a lower threshold to pursue diagnostic imaging resulting in 
identification and initiation of anticoagulation therapy for more small, subsegmental (distal) PE 
that maybe would not have been fatal to begin with.  Controversy exists if the benefit outweighs 
the risk in pursuing treatment of these small emboli as currently there is limited literature 
investigating this issue.  Currently, a prospective, observational cohort study is underway to help 
answer the question of if it is safe to withhold treatment in those patients with subsegmental PE 
and negative bilateral lower extremity CUS (NCT01455818).10,14 
With all testing options available in the evaluation for PE, CTPA currently remains the 
preferred initial imaging modality for confirmation of this disease.  In those patients with 
negative or indeterminate CTPA results but high clinical suspicion of PE, controversy exists as 
to whether patients should be further evaluated by CUS, V/Q scans and/or PA.10 However, these 
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tests still have a role for patients with suspected PE and in which CTPA may be unavailable or 
contraindicated.   
Despite the currently available diagnostic tests and protocols that exist for the evaluation 
of PE, this complex condition continues to be underdiagnosed and have a high mortality rate.  
Given the above described challenges in evaluating PE, other imaging modalities have been 
explored to help improve the sensitivity, efficiency and inclusivity in the diagnostic approach to 
PE. 
 What is POCUS? 
Point-of-care ultrasound refers to the use of portable ultrasonography at the bedside by 
non-radiology physicians and advanced practice providers for the care of acute and critically ill 
patients.  The most common application of POCUS has been in the emergency department (ED) 
and in intensive care units (ICUs) where efficient evaluation is crucial to help determine possible 
pathology and a strategy for management and intervention.15   
Point-of-care ultrasound differs from the conventional, consultative ultrasonography 
evaluation in several ways.  First, the examination is performed by the managing clinician rather 
than skilled technicians completing the ultrasound exam with consulting radiologists or 
cardiologists interpreting the results.  This clinician is responsible for all interpretation as well as 
integration of the images obtained into the management of the patient.  This oftentimes is of 
benefit as information obtained can immediately be used to help narrow a differential diagnosis 
and direct patient care.9,15 Second, the POCUS examination is not comprehensive and usually is 
used to answer a specific question about a condition or help assist with procedural goals.  
Although POCUS can be a useful exam itself, it is crucial for the safety of patients that clinicians 
recognize when POCUS does not provide definitive evidence and standard imaging or 
POCUS vs CTPA and PE  
  12 
 
consultative ultrasound examination is required to ensure accurate diagnosis in complex or 
critical cases.15 The location and timing in which these two evaluations may also differ.  Often 
consultative ultrasonography is postponed until a patient is hemodynamically stable and may be 
done at the bedside or require the patient to be transported to the echocardiology and/or 
radiology department; whereas POCUS has the advantage of always being performed at the 
bedside and, therefore, the stability of the patient does not preclude completion of the 
examination.9,15 
The use of POCUS has been gaining increased acceptance as a supplement to the 
physical examination of a patient.  The American Academy of Family Physicians has published a 
document for recommended curriculum guidelines for POCUS and states that when POCUS is 
utilized with the physical exam it, “…offers additional anatomic, functional, and physiologic 
information to guide patient care.”16  In 2012, the Accreditation Council for Graduate Medical 
Education (ACGM) selected POCUS as one of its required competencies to the curriculum for 
emergency medicine residents.16 Many medical institutions have also already incorporated 
POCUS training into their curriculum as an adjunct to the physical exam.  Given this imaging 
modality is being increasingly used by clinicians, several national and international organizations 
now offer training and certifications programs for various types of POCUS for those that have 
not yet had POCUS education included in their curriculum.  Aside from emergency medicine, 
standards are still being developed for other areas of practice. 9 
POCUS in Cardiopulmonary Pathology 
The use of POCUS has wide-ranging applications.  Multiple terms have been proposed 
for various more specific types of POCUS and this paper will focus on those described 
specifically for cardiopulmonary use.  Terms and abbreviations for variations of single organ 
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POCUS that have been proposed include: lung ultrasonography (LUS), thoracic or transthoracic 
ultrasonography (TUS; including include lung, pleura and/or heart), vascular (CUS), cardiac 
(including echocardiography) and multiorgan ultrasound (which includes ultrasound in two or 
more of the aforementioned locations).15  In addition to the previously described use of CUS for 
vascular POCUS, various protocols have been developed to help standardize the use of bedside 
ultrasound in other cardiopulmonary areas to guide clinicians for observed signs to hone in on 
pathology.  Examples of proposed algorithms include the bedside lung ultrasound in emergency 
(BLUE) protocol and the focused cardiac ultrasound (FOCUS).15,16 
Thoracic and LUS are currently utilized by clinicians to help differentiate common 
causes of acute cardiopulmonary compromise such as pneumonia, pulmonary edema, pleural 
effusion, and pneumothorax in critically ill patients.15  The diagnosis of PE has also been 
included in this list in some studies given the overlap of presenting symptoms and inclusion in 
the differential diagnosis for these conditions.  The use of TUS has been reported to be similar or 
superior to chest radiography in detecting pneumothorax, pneumonia and consolidation in 
pulmonary effusion.15 The BLUE protocol, for example, contains an algorithm that helps guide 
clinicians in determining the etiology of acute respiratory failure through examination of 
anterior, lateral and posterolateral points on the thorax bilaterally as well as the addition of CUS 
(multiorgan POCUS).17  When this protocol is used, POCUS provided a correct diagnosis for the 
underlying etiology of respiratory failure in 90.5% of cases – including in 21 cases of PE.17,18,19    
Ultrasound has potential for improving the diagnostic evaluation of PE given when 
vascular occlusion occurs, the resulting atelectasis with extravasation of blood or infarction of 
lung tissue results in consolidation in peripheral lung parenchyma and can be visible on lung 
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ultrasound.2 Ultrasound characteristics that are associated with some cardiopulmonary causes of 
respiratory compromise are summarized in Table 2.15,17,20  
The use of the BLUE protocol has been shown to significantly reduce the time from 
admission to diagnosis to initiation of treatment for the underly cause of respiratory distress in 
the ED.18 Therefore, this illustrates that POCUS is already being applied to help narrow down the 
differential diagnosis for presentations of respiratory compromise and in some cases may be of 
use to help gather information that may help find alternative etiology to rule out PE versus lead 
to an expedited diagnosis. 
Pulmonary embolism can also have cardiac manifestations that lend to detection on 
cardiac ultrasound.  Historically, the presence (or absence) of right ventricular (RV) strain has 
been viewed on transthoracic echocardiography (TTE) and can help differentiate the severity of 
PE (i.e., massive versus lower risk) and predict mortality.18  However, cardiologists typically 
perform TTE and therefore this examination may not be available or have delays when needed.17 
The FOCUS protocol has been proposed to help standardize the characteristics of RV strain on 
ultrasound and may include the following: the measurement of tricuspid annular plane systolic 
excursion (TAPSE; measurement <17 mm), RV enlargement with comparison to left ventricle 
(LV) size (RV to LV ratio >1); or presence of septal flattening, tricuspid regurgitation (on color 
Doppler), or McConnell’s sign (RV hypokinesis with apical sparing).21,22,23  In a retrospective 
chart review study by Taylor et al in 2013, the authors evaluated the ability of ED providers to 
utilize a point-of-care FOCUS exam in patients with suspected PE.  Of the 161 patients with 
confirmed diagnosis of PE by either CT (n=127), V/Q study (n=19) or clinically if evidence of 
DVT found on CUS (n=6) that received a FOCUS exam, RV strain found by ED providers was 
the, “single most important prognostic factor found to predict adverse outcomes.”21  This study, 
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although did not compare the sensitivity of FOCUS in diagnosing PE, demonstrates that the use 
of cardiac POCUS likely has a role in the urgent evaluation of PE where consultant cardiology 
ultrasound is not readily available. 
Literature Review: Sensitivity of POCUS compared to CTPA for PE detection 
   In order to understand the role POCUS may play in the evaluation of PE, a comparison 
to the currently accepted gold standard diagnostic test of CTPA must be explored.  Given that 
POCUS has been used in both single (TUS, LUS, cardiac ultrasound/echocardiography and 
vascular) and multiorgan ultrasound applications, literature pertaining to each will be evaluated 
with a focus on TUS/LUS and cardiac single organ ultrasound as CUS has been previously well 
studied and accepted in the use for DVT evaluation.10 
Single organ POCUS: thoracic and lung  
 Thoracic ultrasound encompasses imaging of both the lung and pleura and often the name 
is used interchangeably with LUS or chest ultrasound when described in the literature.  One of 
the earlier, small studies conducted to evaluate TUS was done by Mathis et al in 1993 who 
sought to investigate results observed by the previously reported early studies from the 1960s.7,8 
In this study, 58 patients who presented with symptoms concerning for PE were consecutively 
enrolled and received an initial “chest ultrasonography” examination.  The diagnosis of PE was 
verified using ventilation-perfusion lung scanning and PA and reported ultrasound to have a 
sensitivity of 98%, a specificity of 60% and an overall accuracy of 90% in PE diagnosis.8  
Although this study used a diagnostic method different from this paper’s research question, it is 
worth mention for comparison, as this group of investigators went on to later do a larger, similar 
study using CTPA (to be discussed later in this paper).  Given the use of CTPA was not routinely 
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available and used in studies until the twenty-first century, the research in this paper will focus 
on those studies published after the year 2000.   
 The predominance of studies that exist for the use of single organ TUS/LUS in the 
evaluation of PE include small, prospective, observational studies (see Table 3 for a summary of 
studies reviewed).  Four studies exist earlier in the twenty-first century comparing TUS to single-
row CTPA.4,24,25,26 Reissig et al began comparing CTPA to TUS in two separate, small 
observational studies that yielded similar results in 2001 and 2004.4,24  In 2001, 69 patients with 
symptoms suspicious for PE were consecutively enrolled compared to 62 patients in the 2004 
study.  In both studies, single-row CTPA was used as the reference diagnostic test but was only 
able to confirmed the diagnosis of PE in 46-50% of the suspected PE cases alone; the remaining 
patients required additional testing for diagnosis confirmation (e.g., V/Q scan, CUS, 
echocardiography or D-dimer). 4,24 The overall incidence of PE in the two studies was 64% in 
2001 and 63% in 2004.  It was disclosed in the 2001 study that only 62 of the 69 subjects 
received CTPA exams for evaluation of PE and noted that the modality was “unavailable” for 
unspecified reasons. 4 It was also noted in this study that an additional 138 patients had suspected 
PE during the study period, but these patients were not included in the study as TUS was “unable 
to be performed” (again, reasons for inability to complete ultrasound in these patients was not 
specified).4 This method of subject selection in the 2001 Reissig et al study may lend to 
inaccurate representation and bias of the patient population included.  Additionally in this study, 
of those patients with a “correct positive” diagnosis of PE on TUS (n=35), only 32 of them 
received CTPA exam for comparison with the other patients still having a diagnosis consistent 
with the alternative criteria.4  While this makes comparison of TUS to the standard diagnostic 
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imaging for PE difficult, it may support that when contrast-enhanced imaging is unavailable, the 
use of TUS may be helpful in evaluating PE. 
When TUS was compared to all patients with confirmed PE diagnoses in the Reissig et al 
2001 study, the detection of was similar to the 2004 study with a reported sensitivity of 80% and 
77%, respectively, and a specificity of 92% and 91%, respectively.4,24  It should be noted that 
historically the sensitivity of single-row CTPA alone in other studies has been reported to be 
only 76% in the diagnosis of PE.3  While the sensitivity observed in these two studies by Reissig 
et al are comparable or exceed previously reported sensitivity for single-row CTPA, it remains 
inferior to more recent advancements in multidetector CTPA. 
An additional small pilot study was conducted by Mohn et al in 2003 with the goal to 
investigate the diagnostic performance of TUS in those patients presenting with suspicion of 
PE.25 This study a similar validation strategy as Reissig et al with consecutively enrolling 
patients and comparing the results of TUS to diagnostic references tests performed by clinicians 
blinded to each other’s exam.  Diagnostic criteria for PE included: CTPA with evidence of filling 
defects or occlusion of pulmonary arteries outlined by contrast media (however, details of the 
type of CT were not specified in the study to compare to the above two studies), high clinical 
probability and V/Q scan, DVT on CUS and abnormal lung scan or PA. 25  A total of 74 patients 
were enrolled with 31 patients (42%) confirmed to have a diagnosis of PE based on the various 
reference tests25.  Of those enrolled, CTPA was performed in 52 patients and confirmed the 
diagnosis of PE in only 15 subjects for comparison to TUS.25   Therefore, in the 22 patients 
reported to have a had a PE positive TUS result, only 68% of them were confirmed by CTPA in 
this study.  Overall, when TUS was compared to all reference diagnostic tests, the sensitivity was 
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reported to 71% and a specificity of 77%.25  It was concluded by the authors that TUS alone was 
not an accurate overall test to confirm nor exclude the diagnosis of PE.25    
One of the largest studies available to evaluate single organ TUS use in PE evaluation 
was subsequently conducted by Mathis et al in 2005.26  In their prospective, multicenter study of 
TUS in the evaluation of PE, they also used single-row CTPA as their reference test of choice to 
initially confirm diagnosis of PE.  Similar to Reissig et al, if imaging results were negative or 
inconclusive, they alternatively used clinical algorithms for diagnosis and comparison to 
TUS.4,24,26 The TUS exam in this study was differentiated into four categories based on the 
number of lesions and/or signs of pleural effusion detected: PE- confirmed, PE-probable, PE-
possible and normal.  A total of 352 patients were included in the analysis of this study with 194 
(55%) diagnosed with PE; of these, 169 patients (87%) were diagnosed with PE using CTPA.  
When TUS categories were compared to CTPA, the PE-confirmed and PE-probable groups had a 
combined sensitivity of 74% and specificity of 95% and an overall accuracy of 84%.  It was also 
reported that TUS detected significantly more lesions while demonstrating a congruence with the 
size and location of those lesions found on CTPA.  The authors speculated that TUS may have 
the capability to detect a larger number of smaller lesions compared to CTPA.26 However, this 
may or may not be an advantage to TUS over CTPA when considering the controversy 
surrounding if all lesions require anticoagulation therapy. 
As imaging technology advanced to include multi-row CTPA, additional studies were 
performed to compare the performance of TUS to this evolving reference test.  Four subsequent 
studies were published between 2010 and 2018 comparing TUS in a similar research design to 
the above four earlier studies, but this time utilized multi-row detector CTPA in all patients with 
suspected PE.27-30  In 2010, Pfeil et al found that in 33 patients presenting with symptoms of PE 
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and received both multi-row CTPA and TUS, 10 patients were diagnosed with PE by CTPA but 
only 7 patients had both positive TUS and CTPA, reporting a sensitivity of TUS to for detecting 
PE to be only 70% with a specificity of also 70%.27 This study reported the lowest sensitivity of 
all single organ TUS studies reviewed for this paper but likely can be attributed to the fact that a 
more sensitive reference test was used in this study compared to earlier studies and/or the very 
small sample size.  Comert et al conducted a similar study in 2013 with a somewhat larger 
sample size (n=50); of which 60% were diagnosed with PE by multi-row CTPA and 27 patients 
had a true positive TUS (54%).28  However, this group did sub-analysis dividing subjects into 
subgroups based on the quality of TUS findings.  They reported a sensitivity of 43% and 
specificity of 75% for those patients who had two or more characteristic lesions (wedge, 
triangular or rounded) with or without pleural effusion, sensitivity of 70% and specificity of 65% 
for those patients with the one characteristic lesions plus pleural effusion and a sensitivity of 
90% and specificity of 60% when the two groups were combined.28  Furthermore, in a 
prospective observational study in 2017 by Acar et al enrolling 100 patients, 38 patients received 
multi-row CTPA confirming diagnosis of PE.29  Of the patients that had positive signs for PE 
(three or more B-lines in one area, one or more signs of wedge lesions or pleural effusion), it was 
those with the characteristic wedge sign alone for detection of PE on ultrasound showed the 
highest sensitivity of 42% with a specificity of 98% (data for groups combined were not 
analyzed).29 These two studies illustrates that the criteria for obtaining a positive TUS/LUS for 
diagnosing PE likely needs standardization for the characteristics found on ultrasound to help 
optimize the sensitivity of the test when used.  Furthermore, it illustrates that TUS has lower 
specificity and a negative examine alone cannot be used to rule out the diagnosis of PE.   
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Lastly, the most recent study conducted by Ghanem et al in 2018 investigated the use of 
TUS compared to multi-row CTPA in diagnosing PE but also additionally looked at how gray-
scale TUS compared to doppler ultrasound.30 The criteria for a positive TUS finding used was 
similar to Comert et al and Pfeil et al.29,30 A total of 60 patients with suspected PE received TUS 
and CTPA; of those, 40 patients were confirmed to have a diagnosis of PE with multi-row CTPA 
and 33 patients had evidence of PE on grey-scale TUS yielding a sensitivity of 82% with a 
specificity of 90%.  Additionally, it was noted that the addition of color doppler only increased 
the specificity to 95% while decreasing the sensitivity to 80%.30   
Two recent meta-analyses exist published investigating the role of TUS and/or LUS in 
the diagnosis of PE.31,32 In 2013, Squizatto et al attempted to evaluate the diagnostic accuracy of 
LUS by selecting studies in which any patient with suspected PE received LUS plus “at least, an 
imaging test” and evaluated the sensitivity and specificity of LUS; no study was excluded based 
on the type of reference standard used and there was no restriction to language. 31  Ultimately, ten 
studies were included (two of which were in German) that spanned the years 1990-2010.31    
Therefore, four of the studies occurred prior to the year 2000 and four did not utilize CTPA for a 
reference test comparison in diagnosing PE (alternatively used PA, V/Q scans or autopsy).31  Of 
the other six studies conducted in 1999 or later, one used MRI as the reference test, four used 
“composite” reference tests that included CTPA (single-row) and/or historical standards 
described previously and only one study (from 2010) used multi-row CTPA for confirmation of 
PE diagnosis.  Cumulatively, PE was diagnosed in 507 patients and LUS showed positive 
symptoms of PE in 417 patients reporting a pooled sensitivity of 87% (95% CI, 80-92%); 
additionally, LUS was reported to be negative (normal) in 324 of the 380 patients who had PE 
negative diagnostic tests resulting in a pooled specificity of 82% (95% CI, 71-89%).31 However, 
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given this study included variable diagnostic reference tests and potentially with lower 
sensitivity, the reported diagnostic accuracy of LUS in this analysis may be inflated.   
In 2015, Jiang et al recognized weaknesses in the meta-analysis by Squizatto et al and 
repeated a systematic review and metanalysis that included 13 studies spanning the years 1990-
2013 and 1356 subjects.32 However, Jiang et al also performed sub-analysis for those studies 
performed prior to the year 2000 versus post-2000 to minimize the influence single versus multi-
row CPTA may have had in the comparison of LUS to CTPA.  When all studies were analyzed 
together, the pooled sensitivity of LUS in diagnosing PE was 85% (95% CI, 78-90%) with a 
specificity of 83% (95% CI, 73-90%).32 When sub-analysis was performed on the five studies 
conducted prior to the year 2000, the pooled sensitivity was 94% (95% CI, 89-96%) and 
specificity was 74% (95% CI, 61-85%); comparatively, in those studies performed after the year 
2000, the pooled sensitivity was 77% (95% CI, 70-83%) and specificity was 88% (95% CI, 78-
94%).32 This supports the previously stated hypothesis that earlier (less sensitive) diagnostic 
methods for PE likely falsely inflated the accuracy of LUS and/or TUS in evaluating PE. 
 Single organ POCUS: cardiac  
  The use of cardiac POCUS (echocardiography) to evaluate for RV dysfunction through a 
FOCUS exam has been reported to increasingly help ED providers gain information to 
differentiate the symptoms of chest pain or dyspnea.22  Four studies prospective, observational 
studies were found examining the use of cardiac POCUS alone in diagnostic work up for 
PE.22,23,33,34 In three of these studies, single cardiac POCUS was evaluated in comparison of the 
use of multiorgan POCUS and details of the studies will be discussed elsewhere (see 
“Multiorgan POCUS”) as well as summarized in Table 3.23,33,34 The results of these three studies 
showed high variability in sensitivity of cardiac POC ranging from 48-92% for the diagnosis of 
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PE.23,33,34 Additionally, Daley et al investigated the use cardiac POCUS in a prospective, 
observational study in which a convenience sample included 150 patients who were being 
evaluated for suspected PE.22 Subjects included were those that had CTPA and were able to have 
a FOCUS exam completed when ED clinicians were available to do so (convenience sample). 
The authors in this study focused on the sensitivity of the TAPSE portion of the FOCUS exam, 
how varying the TAPSE measurement affected sensitivity as well as how TAPSE compared to 
other components of the exam. 22 A total of 32 patients had PE diagnosed by CTPA but did not 
specify the number of patients from the total sample that had positive FOCUS exams.  The 
authors reported that a FOCUS exam using a TAPSE of 20 mm had the highest sensitivity of 
72% compared to 56% when the standard recommendation for a TAPSE of 17 mm was used; for 
all other parameters usually included in a FOCUS exam (i.e., RV enlargement, “D” sign or septal 
flattening, tricuspid regurgitation or McConnel’s sign), the sensitivity ranged from 13-43% (the 
authors did not report the overall sensitivity for all components of the FOCUS exam).22 
However, it was noted in post hoc analysis that when those patients who were diagnosed with a 
PE and initially presented with symptoms of tachycardia and/or hypotension (n=17), the 
sensitivity of TASPE alone in the FOCUS exam was 94% and 100% when all components were 
combined in analysis for these patients.22 In the other three studies reviewed, only Dwyer et al 
included TAPSE in their FOCUS evaluation and also reported this criteria to have the highest 
sensitivity out of the FOCUS components but still remained low at only 37%.23  Furthermore, in 
the study by Mansencal et al they also reported a higher sensitivity of a cardiac POCUS exam 
(72% compared to 55%) for patients diagnosed with PE that presented with symptoms of 
dyspnea.33 These findings highlight the importance of evaluating the components of protocols 
used in single organ POCUS as well as their utility in specific symptom presentations of PE.   
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Multiorgan POCUS 
The comparison of the aforementioned single organ ultrasound studies highlights the 
variable and suboptimal sensitivity that exists with single organ POCUS.   It further illustrated 
that even when single organ ultrasound use is intended, oftentimes additional ultrasound 
modalities, namely CUS and cardiac ultrasonography (echocardiography), have been utilized as 
well to help ensure accurate diagnosis of PE or when CTPA is inconclusive, unavailable or 
contraindicated.  Given this trend, additional studies have gone on to investigate if combined use 
of various single organ modalities will improve the diagnostic accuracy of POCUS.  Studies of 
multiorgan POCUS exist as early as 1998 but, given more sensitive diagnostic confirmatory 
imaging for PE was not available at this time, this paper will focus on those multiorgan POCUS 
studies only including comparison with CTPA.35 
The term “triple” POCUS has been coined to describe one modality of multiorgan 
POCUS that includes the use of combined LUS/TUS, vascular (including CUS and/or IVC 
evaluation) and cardiac ultrasound.  Two studies were found investigating the use of triple 
POCUS6,13 but only one evaluated the sensitivity and specifically for use of triple POCUS in PE 
diagnosis.  Nazerian et al conducted a multicenter, blinded, prospective accuracy study in 2014 
comparing the use of triple POCUS (LUS, cardiac and vascular/CUS) to confirmed diagnosis of 
PE by multi-row CTPA in 357 patients presenting with clinical symptoms suspicious for PE.6  Of 
the total number patients enrolled, 133 had a positive multiorgan POCUS exam and 99 of those 
patients had a confirmed diagnosis of PE yielding a sensitivity of 90% and a sensitivity of 86%. 
The authors of this study also provided sub-analysis for each single system POCUS and reported 
the following for sensitivity and specificity: 61% and 96% for LUS alone, respectively; 33% and 
91% for cardiac alone, respectively; and for vascular (CUS) 53% and 98%, respectively.6 This 
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study combining single and multiorgan POCUS comparisons, illustrates previous conclusions 
that single organ POCUS is insufficient alone for diagnosis of PE but that the use of triple 
POCUS may increase the potential of this modality for sensitive diagnosis of PE.   
More recently, Zanobetti et al attempted to evaluate the use of multiorgan POCUS (LUS, 
cardiac) in patients with a broader clinical presentation and differential work up for acute 
dyspnea.36  In a prospective, blinded, observational study consecutively enrolling a total of 2683 
patients with symptoms of dyspnea in the ED, multiorgan POCUS was performed in addition to 
routine PE evaluation (including confirmatory contrast CT scans).36  Of these patients, 95 were 
diagnosed with PE and 41 of those had a positive multiorgan POCUS exam yielding a sensitivity 
of 40% and a specificity of 100%.36  It was also noted that multiorgan POCUS had higher 
sensitivity and specificity to help in establishing alternative diagnoses in the differential for 
dyspnea (including pneumothorax, pneumonia and pericardial effusion).36 Although multiorgan 
POCUS did not perform well as a diagnostic tool for ruling in PE, it had high specificity for 
helping to exclude PE as the underlying cause of dyspnea. 
Other combinations of POCUS have also been investigated for the use of multiorgan 
POCUS in detection of PE.  In another study, designed similarly to Zanobetti et al, Lichtenstein 
et al evaluated patients with a presenting symptoms of dyspnea using a dual POCUS exam (LUS 
plus CUS) to study the accuracy of the previously described BLUE protocol.17, 36 A total of 260 
patients received a dual POCUS examination in addition to standard diagnostic tests (including 
helical CT for suspected PE).17  Among these patients, 21 received a diagnosis of PE with 20 of 
those patients having a positive LUS exam and 17 having a positive CUS exam; when the 
patients who had both positive LUS and CUS exams were considered, the dual POCUS exam 
demonstrated a sensitivity of 81% with a specificity of 99%.17 The authors concluded this 
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method is more advantageous in ruling out PE in that it also helps to find alternative etiologies 
for patients presenting with symptoms of dyspnea and reported was able to correctly diagnosis 
the underlying cause of respiratory compromise in 90.5% of patients to expedite management.17  
This is yet another study that illustrates the value-added use of multiorgan POCUS in patients 
with respiratory presentations that may or may not include PE.   
In a similar study design, Bataille et al evaluated the use of an alternative dual POCUS 
including LUS and cardiac ultrasound (echocardiography) in accurately diagnosing the cause of 
acute respiratory failure (including symptoms of tachypnea, hypoxia on room air with respiratory 
acidosis).37  Of the 136 patients presenting with symptoms of acute respiratory failure and 
received the dual POCUS exam plus a standard diagnostic work up (including CT), 13 received a 
final diagnosis of PE with five of those patients showing a positive dual POCUS exam yielding a 
sensitivity of 83% and a sensitivity of 84%.37 The authors also performed sub-analysis in this 
study for single organ LUS alone for comparison with a resulting sensitivity of 67% and 
specificity of 94% and concluded that the dual approach was favorable compared to single LUS 
for diagnosis of PE. 37 This study also demonstrated that this form of dual POCUS had greater 
accuracy in diagnosis other etiologies such as cardiogenic edema and pneumonia.37 When 
considering both the results of Lichtenstein et and Bataille et al with a population of patients 
presenting with symptoms possibly less specific for PE (i.e., acute respiratory failure), it still 
resulted in similar suboptimal sensitivity for diagnosis of PE but provided a means to help rule 
out PE and uncover other underlying etiologies to explain the cardiopulmonary pathology. 
Another multiorgan POCUS combination that exists and has been investigated in the use 
of diagnosing suspected PE is another dual modality of cardiac ultrasonography 
(echocardiography) plus CUS.  Three prospective observational studies evaluated the diagnostic 
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accuracy of how this dual multiorgan POCUS compares to CTPA.23,33,34 Mansencal et al 
attempted to evaluate if form of dual POCUS could help triage patients in the ED with suspected 
PE and conducted a prospective, blinded, observational trial consecutively enrolling 76 patients 
that presented to the ED with concern for PE after D-dimer screening was completed.33  All 
patients received echocardiography plus CUS using a portable ultrasound device at the bedside 
and measured for symptoms of RV strain as previously described and CUS for signs of DVT.33  
Of the patients enrolled, 31 patients had PE diagnosis with a majority confirmed by CTPA (only 
three patients required an additional V/Q scan to confirm the diagnosis) and 41 patients had a 
positive dual POCUS exam with a reported combined sensitivity of 87% and a specificity of 
69%.33 To further evaluate the impact that more than one POCUS modality has on the accuracy 
of PE diagnosis, the authors also reported single organ POCUS results for comparison with 
echocardiography alone demonstrating a sensitivity of 55% and specificity of 69% while CUS 
alone had a sensitivity of 58% with a specificity of 93%.33   
In a similar prospective multicenter observational study evaluating the same multiorgan 
combination described above, Dwyer et al used the FOCUS protocol, including TAPSE, for 
cardiac ultrasound plus CUS in evaluating 199 patients with suspected PE that were undergoing 
CTPA (but the number of detector rows in the CTPA was not specified in the study).23 The dual 
POCUS exam was considered positive if the patient had any abnormal findings on either 
modality of ultrasound.  The prevalence of PE diagnosis in this group was 46 patients (26 with 
peripheral PE compared to 20 with centrally located PE) and total of 42 patients had positive 
POCUS findings (20 patients had a positive CUS, 22 had a positive FOCUS exam and 32 
patients had either a positive CUS or FOCUS exam).23 For those patients with a positive FOCUS 
exam alone (single organ cardiac exam), the reported sensitivity was 48% and specificity was 
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88% regardless of the location of the PE; however, in the “either” group when CUS was also 
considered (multiorgan POCUS), the sensitivity for PE increased to 87% with a specificity of 
69% regardless of location of PE.23  It was also reported in the text of the results section of this 
article (no table summarizing data available) that when considering the location of the PE, the 
sensitivity for the “either” group decreased to 46% for peripheral (distal) PE but increased to 
100% for centrally (proximally) located PE.23  This suggests that the use of a POCUS strategy 
that includes cardiac plus CUS helped to identify patients with DVT that may have gone 
undiagnosed until they manifested as higher risk PE. 
One final study worth inclusion in the comparison of cardiac POCUS studies, is that 
performed by Filipiak-Strezecka et al recently in 2018.34 This prospective observational study 
investigated the use of a multiorgan POCUS approach also including cardiac ultrasound and 
CUS and utilized a pocket-size portable ultrasound device. 34 A total of 100 patients presenting to 
the ED with 15 patients having a positive CUS exam, 59 patients had a positive cardiac 
ultrasound exam showing RV enlargement and a total of 24 patients had confirmed PE diagnosis 
by CTPA.34 In those patients who had both a positive CUS and cardiac ultrasound exam, the 
reported sensitivity was 54% with a specificity of 100% as well as a positive predictive value for 
PE of 100%; when data was analyzed for those with a positive CUS or a positive cardiac 
ultrasound exam, the sensitivity was 92% with a specificity of 49%.34 The authors also analyzed 
the sensitivity and specificity of each single organ POCUS modality for comparison and reported 
54% and 97%, respectively, for CUS alone and 92% and 51%, respectively, for cardiac 
ultrasound alone.34 It was also noted that when this exam was incorporated into the physical 
assessment it took approximately five minutes to perform.34 These results suggest that when this 
exam is incorporated to the clinical assessment of a patient with suspected PE, it may help 
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clinicians increase their suspicion early on for the diagnosis of PE and lead to expedited and 
improvement of this disease.  
METHODS 
A literature search was conducted via the Augsburg Library search engine but included 
libraries worldwide.  Peer reviewed articles were requested in the search for primary literature.  
Databases searched included MEDLINE, Science direct, Pubmed, Google Scholar and 
UpToDate.  Additionally, review articles that were commonly cited in the review of references 
from other articles retrieved were obtained reviewed as well when not obtained through the 
above search.  Only articles available in English were utilized.  Article titles and abstracts were 
reviewed for inclusion of any type of POCUS (single organ or multiorgan) as well as CTPA in 
the evaluation of POCUS; if details of either were not available in the abstract, articles were 
obtained for more thorough examination to see if met this criteria for comparison and inclusion. 
Search terms and abbreviations utilized in this research included: pulmonary embolism 
(PE), point of care ultrasound (POCUS), computed tomography pulmonary angiography 
(CTPA), lung ultrasound, multiorgan ultrasound, thoracic ultrasound, cardiac ultrasound, 
diagnosis and sensitivity. 
Studies included in the literature review included those performed in adult (> 18 years 
old) human subjects and excluded animal studies in order to better apply findings to the general 
population.  Literature reviewed included systematic reviews, meta-analyses, prospective 
observational studies, retrospective chart reviews and case reports. 
DISCUSSION  
Despite advances in imaging technology and the use of clinical algorithms to help guide 
systematic diagnostic management of PE, it remains a disease that is frequently underdiagnosed, 
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undertreated and a fatal complication of VTE.  Currently multi-detector row CTPA remains the 
gold standard given it has both high sensitivity and specificity but can still produce false-
negative results, has a lower sensitivity for peripheral (distal) PE, is not always readily available 
and is contraindicated in some cases. Additionally, CTPA is only helpful when it is obtained and 
the potential for an inaccurate clinical probability assessment exists that can lead clinicians away 
from obtaining CTPA in those still with PE.  Therefore, one could argue that any additional 
diagnostic information that may add to the efficiency and accuracy (ruling in and/or ruling out) 
of PE evaluation should be considered and further investigated. 
Based on this review of existing literature investigating the use of single and multiorgan 
POCUS in the diagnosis of PE, the sensitivity of both modalities varies considerably (see Table 
3).  Overall, both modalities still proved to have inferior sensitivity to CTPA.  In single organ 
POCUS studies for TUS/LUS, sensitivity ranged from 71-80% for single-row CTPA compared 
to 61-90% with for multi-row CTPA (if omit the data from Acar et al since they did not provide 
a combined sensitivity result for comparison).  The lower range results for the multi-row CTPA 
comparison may be explained by the findings Jiang et al reported in the previously mentioned 
meta-analysis that when studies prior to 2000 were omitted in analysis the overall sensitivity was 
lower likely due to the comparison to the more sensitive multi-row CTPA.32   
It is difficult to compare results of multiorgan POCUS sensitivity across the board given 
the different combinations of POCUS used.  However, in the five studies reviewed that provided 
analysis of the sensitivity of single organ POCUS modalities compared to that of combined 
individual POCUS components, multiorgan POCUS had higher sensitivity for all five 
studies.6,23,33,34,37 However, it should be noted that in the study done by Filipiak-Strezka et al, the 
multiorgan POCUS did report a lower combined sensitivity of 52% for cardiac POCUS and CUS 
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compared to individual component sensitivities of 92% for cardiac POCUS and 54% for CUS; 
but, the overall sensitivity increased to 92% when cardiac POCUS or CUS were compared.34 Of 
these five studies found investigating the use multiorgan POCUS in PE diagnosis, only the study 
by Nazerian et al using a triple POCUS approach reported sensitivity and specificity that came 
somewhat close to that of CTPA but still remained inferior (triple POCUS 90% and 86%, 
respectively compared to the reported CTPA performance of 96-100% and of 97-98%, 
respectively).2,3,6  
The heterogeneity of studies performed not only in single organ but also multiorgan 
POCUS studies also likely lends to the variable results.  Not all studies enrolled patients in the 
same manner with some using convenience samples and some not utilizing consecutive 
enrollment lending to bias (see Table 3).  In the studies by Bataille et al, they alternatively 
enrolled patients with symptoms of “acute respiratory failure” (and possibly a lower initial 
suspicion of PE initially?) and overall had lower prevalence of PE in the enrolled patients (10%) 
with a reported sensitivity for single organ LUS to be 67% compared to multiorgan POCUS 
(LUS plus cardiac) of 83%.37  Lichtenstein et al reported a similar sensitivity of 81% with similar 
selection criteria and prevalence (8%) but utilized a multiorgan POCUS approach of LUS and 
CUS (the BLUE protocol).17  This may suggest that even when there may be lower suspicion of 
PE, POCUS may still have some value in helping to diagnose PE as the underlying etiology of 
acute respiratory failure. 
One critique to the design of those studies that included blinding of the POCUS 
examiner.  In these studies, the clinician performing the POCUS exam were non-
radiology/cardiology clinicians that were usually not involved in the management of the patient 
and were blinded to the CTPA results (oftentimes the exam was done prior to the CTPA or soon 
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thereafter without the results being available to the POCUS examiner).  While important to avoid 
having CTPA results influence the interpretation of the POCUS exam it would likely be 
performed by the managing clinician with additional information about the clinical case and 
could also alter the results. 
  The existing single organ POCUS studies also varied in size with a majority having 
smaller sample sizes.  However, when considering the two largest studies using TUS, Nazerian 
et al and Mathis et al still only reported the sensitivity of TUS to be 61-74% with the higher 
value from the Mathis et al study which used single row CTPA likely yielding a falsely elevated 
reported sensitivity for LUS/TUS and also did not consecutively enroll patients possibly 
contributing to bias in patient selection.6,26  These findings suggest that the sensitivity of TUS 
alone at best may be consistent with that of single-row CTPA (which has now largely been 
replaced anyway with improved multi-row detector CTPA) and cannot be recommended for 
diagnostic purposes in PE.   
The International Liaison Committee on Lung Ultrasound recognized the emerging value 
that LUS can provide in the evaluation of PE in its published “International evidence-based 
recommendations for point-of-care lung ultrasound” in 2012.38 In this document (which included 
data analysis only through the October 2010), Volpicelli et al gave the following 
recommendations to the following three statements pertaining to PE: 
• “Lung ultrasound should be used in the evaluation of lung consolidation because 
it can differentiate consolidations due to pulmonary embolism, pneumonia, or 
atelectasis.” (strong: level A)38 
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• “Lung ultrasound is an alternative diagnostic tool to computerized tomography in 
diagnosis of pulmonary embolism when CT is contraindicated or unavailable.” 
(strong: level A)38  
• “Lung ultrasound is a clinically useful diagnostic tool in patients with suspected 
pulmonary embolism.” (strong: level B)38 
These recommendations were published prior to the availability of some more recent studies 
(including the larger study by Nazerian et al in 2014) and did not specify if LUS was evaluated 
as single organ POCUS versus integrated into a multiorgan POCUS approach.6,38 No updates to 
these guidelines were found in this literature search. 
Cardiac POCUS alone has also shown variable performance in the diagnostic accuracy 
for PE.  In the studies reviewed for cardiac POCUS (echocardiography) to evaluate for RV 
dysfunction, the sensitivity ranged from 48-92% and the specificity 51-97% depending on the 
criteria used in the cardiac POCUS evaluation (which varied between studies) and the location of 
the PE.  The most promising results for applying cardiac POCUS into PE evaluation were in 
those patients who presented with symptoms of shock or hypotension resulting from central PE.  
Dwyer et al found that cardiac POCUS alone had a sensitivity of 90% in detecting central PE 
(and 100% sensitivity when combined with CUS) but decreased to only 48% for all PE when 
peripheral PE were included in analysis.23 In the most recent (2014) available version of the 
“Guidelines on the diagnosis and management of acute pulmonary embolism” published by the 
European Society of Cardiology (ESC), the use of echocardiography is not recommended in 
those patients who are normotensive with lower risk PE probability; however, it does supports 
the use for PE diagnosis in patients presenting with hemodynamic instability that are too unstable 
to confirm diagnosis with CTPA to allow reperfusion therapy to be immediately initiated.39   
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Given the mortality associated with central emboli, the use of cardiac POCUS for evaluation of 
PE should be reserved for this patient population and may prove to have a significant impact on 
mortality associated with PE.   
 Based on the literature available to date, neither single nor multiorgan POCUS can be 
used as a first line diagnostic tool in the evaluation of PE.  However, it has shown promise as an 
adjunct to the gold standard of CTPA.  In the studies in which patients received LUS or TUS as 
part of either single or multiorgan POCUS, alternative etiology for the presenting symptoms 
were often found in the cases where PE was not the cause.  In a study by Koenig et al in 2014, 96 
patients who presented with clinical suspicion of PE and were able (convenience sample) to 
receive both a multiorgan POCUS exam (using the same triple approach by Nazerian et al in 
2014; cardiac, TUS and CUS) and confirmatory CTPA were enrolled; of these patients, 12 
(12.5%) had a positive diagnosis of PE, two (2%) were also positive for DVT and 54 (56%) had 
an alternative diagnosis found on the triple POCUS exam to explain symptoms (which were 
confirmed by CTPA as well).13 The Koenig et al study is discussed here rather than included in 
the previous review of the literature as the authors, unfortunately, did not provide sensitivity data 
for their triple POCUS diagnostic performance.  Koenig et al estimated that in those patients who 
had alternative diagnosis to PE or DVT found on triple POCUS (56%), those patients could have 
avoided needing CTPA or even other pulmonary radiographs.13  Nazerian et al also reported that 
when multiorgan (triple) POCUS was used in their study, they were able to detect an alternative 
diagnosis in almost one-third of the patients.6   In both these studies, triple POCUS enhanced 
diagnostic management of these patients by 1) providing additional clinical data that would not 
have necessarily been obtained in a timely manner to help narrow in on the differential diagnosis 
for presenting symptoms, and 2) those cases where the POCUS exam preceded CTPA, a 
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theoretical reduction to the amount of radiation exposure.  In fact, a specific endeavor entitled 
the “Lung Ultrasound in the Critically Ill Favoring Limitation of Radiation” project (or LUCI-
FLR project) has been developed to utilize LUS to decrease bedside radiographies by one-third 
and urgent CT by two-thirds in the next three decades.40 
The use of multiorgan POCUS has also been investigated for how it can contribute more 
objective data for application into the prediction rules. Two prospective, observational studies 
have investigated how the integration of clinical data from multiorgan POCUS into the clinical 
prediction rules might improve the diagnostic process for PE.11,34 In an blinded, observational 
cohort multicenter diagnostic accuracy study conducted by Nazerian et al in 2017, the authors 
calculated both the conventional Wells score (Ws) but also created and calculated an alternative 
ultrasound Wells score (USWs) in which two questions were changed to include more objective 
clinical signs obtained from a multiorgan POCUS exam with LUS and CUS.11  The two 
questions that were adjusted were as follows: “signs and symptoms of DVT” was changed to 
“venous ultrasound positive for DVT” and “alternative diagnosis less likely than PE” was 
changed to “alternative diagnosis less likely than PE after lung ultrasound.”11   The scoring points 
assigned to these statements was unaltered and diagnosis for PE was considered “unlikely” still if 
the score was < 4 for either score.11 Of the 446 patients that were consecutively enrolled with 
clinical suspicion of PE and were able to receive the multiorgan POCUS exam within three hours 
(convenience sample), 125 patients were diagnosed with PE with a majority (119) by CTPA 
(five required lung scintigraphy and one by autopsy).  When the USWs was compared to the 
standard Ws, it had a significantly improved sensitivity of 70% compared to 58% (p<0.01).  
Furthermore, in those patients who had a USWs <4 and a negative D-dimer, the failure rate was 
0.8% compared to 1.9% for Ws (although this difference did not meet statistical significance, 
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p=0.33).11  It was estimated that when multiorgan POCUS (LUS and CUS) more objectively 
adjusted the prediction rule (Wells score) and was combined with D-dimer, CTPA could have 
been avoided 50.5% of patients compared to 27% of patients using the Ws.11   
Filipiak-Strzecka et al also investigated how data from a multiorgan POCUS (cardiac and 
CUS) using a pocket-sized ultrasound device to augment the physical exam, may be integrated 
into both the Wells and Geneva prediction rules to improve the efficiency and diagnostic 
accuracy for PE.34 These authors only adjusted the Wells rule for sign and symptoms of DVT to 
include “positive CUS result” but added a criteria for RV enlargement (which could aware one 
point to the score); for the Geneva score, “unilateral lower limb pain” was changed to “positive 
CUS result” and the addition of RV enlargement was added in the same manner as the Wells 
score.34 The threshold for the modified Wells score was changed to > 5 and >7 for the modified 
Geneva score.  The authors reported that there was a significant improvement in diagnostic 
accuracy in the conventional versus modified Wells score (81% versus 93%, respectively; 
p=0.012) as well as in the Geneva score (59% versus 94%, respectively; p=0.02).34 These two 
studies demonstrate that multiorgan POCUS may have multiple roles in the diagnostic process 
for PE.  Based on the findings in these two studies, the ability of multiorgan POCUS to help add 
to the risk stratification of patients presenting with clinical suspicion of PE appears promising. 
One of the main drawbacks to the diagnostic evaluation of PE is that CTPA is not always 
available and cannot be applied to some patient populations.  In some of the reviewed studies on 
both single and multiorgan POCUS, those patients with hemodynamic instability or pregnancy 
were excluded and, based on this review of the literature, no studies are available looking at the 
use of POCUS in these populations.  As stated previously above, the International Liaison 
Committee on Lung US recommendations does support the use of at least LUS as an alternative 
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diagnostic tool when CTPA is unavailable or contraindicated.38 Given the reported higher 
sensitivity of triple POCUS, this seems to be the logical alternative for this patient population 
and a case study reported in the literature illustrates this very point.  Silva et al describe a case in 
which a 26 year-old-man presented to the ED with sudden onset of dyspnea, pleuritic chest pain 
and fatigue. 41   The patient had no previous medical history except for a recent upper airway 
infection and essentially had been on bedrest for three days preceding. 41   His physical exam was 
notable for tachypnea (respiratory rate of 24 breaths per minute), tachycardia (heart rate 115 
beats per minute), oxygen saturations of 92%, a blood pressure of 138/79, crepitus in the left 
lower lung base and swelling of his right leg with normal pulses. 41 A Wells score was calculated 
to be nine (based on clinical signs and symptoms of DVT) and PE was the most probable 
diagnosis. 41 However, CTPA was not available at the time of this patient’s presentation (for 
reasons not specified).  Therefore, the providers applied the triple POCUS protocol and found the 
following: On LUS and A profile was observed on all right lung fields with some B-lines in the 
anterior part of the lung base and a small sub-pleural consolidation in the more posterior 
position; Cardiac evaluation did not show dilation of the RV nor any thrombi; CUS showed a 
right popliteal thrombus.41 Given the finding of DVT on CUS with characteristics of PE per 
LUS, the patient was immediately started on anticoagulation therapy and made a full recovery in 
three days. 41 
CONCLUSION 
Pulmonary embolism remains a common condition that frequently is misdiagnosed or 
goes undiagnosed with fatal consequences.  When treated early, PE has a mortality rate of 2-8% 
but if left untreated the mortality may be as high as 25-30%.32 Therefore, early and accurate 
diagnosis is vital to allow initiation of anticoagulation therapy to appropriate candidates.  The 
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diagnosis of PE presents challenges to clinicians as the symptoms are non-specific.  In the United 
States, over 10 million patients seek care annually for the symptoms of dyspnea, chest pain or 
both with the etiology of PE included in differential diagnosis for these symptoms.34  Currently, 
multi-row CTPA remains the gold standard for diagnosis of PE due to its high sensitivity and 
specificity for detection of PE.  However, this imaging modality has limitations and cannot be 
used in all patient scenarios.  Furthermore, despite improvements in CTPA sensitivity and 
algorithms to guide the diagnostic approach to PE, mortality for this disease remains unchanged 
and new diagnostic techniques should be explored.2,5   
Point-of-care ultrasound has a promising role in the evaluation of PE.  However, based on 
the literature available to date, the sensitivity of both single and multiorgan POCUS remains 
inferior to CTPA and should not be used as a first line diagnostic test.  Triple multiorgan 
POCUS, using cardiac ultrasound (echocardiography), LUS and CUS, has shown sensitivity and 
specificity closer to CTPA when compared to single organ POCUS and should be considered as 
an alternative when the gold standard is unavailable or contraindicated.   
Point-of-care ultrasound has several advantages in the evaluation of PE.  First, POCUS is 
a safe, non-invasive imaging modality that has no contraindications.  Secondly, POCUS is 
readily available for use at the bedside and can be efficiently integrated into the physical exam 
and clinical assessment of a patient early on in admission.  Objective information obtained from 
POCUS can be incorporated into prediction rules to help improve diagnostic accuracy and 
expedite management strategies for patients with suspected PE.  Studies have demonstrated the 
POCUS exam can be done in a timely manner with a minimum average time to complete some 
exams being three minutes (Lichtenstein et al for combined LUS and CUS)17 and a maximum 
time reported was 15 minutes (Mohn et al for TUS)25 in the studies reviewed but likely varies 
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based on the experience of the clinician.  Consideration should be given to include the use of 
POCUS in algorithms that guide the diagnostic management of PE (see Figure 2 for an example 
of one proposed algorithm).  Third, POCUS can provide information to confirm alternative 
cardiopulmonary conditions that present with symptoms like PE and narrow the differential 
diagnosis and rule out PE.  Given this potential, POCUS also has the potential to reduce the need 
for unnecessary imaging.  Fourth, POCUS provides an alternative diagnostic test for those 
patients who may be too unsafe for transport for tests, have contraindications for CTPA or if 
CTPA is not available.  Lastly, as ultrasound technology improves, devices are becoming 
increasingly compact and an inexpensive imaging option that is widely available for use.5 
Despite the potential advantages of POCUS in the evaluation of PE, some issues exist 
that limit the effectiveness and accuracy of this tool.  Variability in training and experience in 
those performing this exam likely will impact the accuracy of POCUS.  While medical schools 
are increasingly incorporating POCUS into their training, variability in curriculum and 
competency exists among clinicians across different areas of practice.5,9,16  Furthermore, a need 
for standardized and validated POCUS protocols exist as evidenced by the variability observed 
in the literature for criteria defining a “positive” POCUS exam.  Additional future opportunities 
for research to help determine how POCUS could improve the diagnostic evaluation of PE could 
include studies that use POCUS in those patient populations currently limited in their diagnostic 
evaluation of PE and cannot receive CTPA; how the addition of multiorgan triple POCUS affects 
the timeline of PE diagnosis, treatment initiation and outcomes; the impact multiorgan triple 
POCUS could have on the prediction rules; and, how the use of POCUS performed by the 
clinical care team privy to patient information would affect the sensitivity of the exam (i.e., 
reality).  Until observational studies can consistently demonstrate that POCUS yields a high 
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sensitivity and specificity to rival CTPA, POCUS cannot replace the gold standard CTPA for the 
diagnosis of PE and randomized controlled trials cannot be safely performed to evaluate these 
two modalities against one another. 
The use of POCUS is seemingly evolving and expanding in multiple clinical facets not 
just pertaining to PE.  Given the compact size of devices as well as increasing use and research 
available on how this tool can enhance the clinical assessment and patient outcomes, I anticipate 
POCUS may soon become integrated into the routine physical exam in many areas of practice 
outside the ED and ICU.  In fact, PCOUS has even been described as an “ultrasound 
stethoscope” or the “stethoscope of the 21st century.”5 As a new physician assistant, it seems that 
acquiring the skill of POCUS would not only enhance my clinical evaluation, but also help me in 
providing accurate and efficient clinical management of my patients.  The use of POCUS would 
be a valuable adjunct or even alternative diagnostic tool in certain situations if I encounter a 
patient with a PE or any other underlying cardiopulmonary condition.  However, it also is 
apparent that sufficient training, practice with this device and staying current with specific 
literature pertaining to POCUS in various conditions seems to be crucial to the successful 
application of POCUS into practice.  In the words of Squizatto et al, “the new era of POCUS has 
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Table 1.  Wells Score and Geneva Score clinical prediction rules for PE 
 
Wells Score*   Geneva Score**  
Variable Points  Variable Points 
Alternative Dx less likely than PE 3  Age > 65 years old 1 
Clinical signs and Sx of DVT (leg 
swelling and pain with palpation 
of deep veins) 
3  Pain on lower limb deep vein 
palpitation and unilateral edema. 
 






Heart rate > 100 bpm 1.5  Heart rate 75-94 bpm 
 




Immobilization for > 3 days or 
surgery in previous 4 weeks 
1.5  Surgery or fracture within 1 
month 
2 
Previous PE or DVT 1.5  Previous PE or DVT 3 
Hemoptysis 1  Hemoptysis 2 
Cancer (with treatment in the past 
6 months or palliative care) 
1  Active malignancy 2 
     
Three-level clinical probability 
assessment  
(Wells criteria) 
Score  Three-level clinical probability 
assessment  
Score 
High >6  High >11 
Moderate 2-6  Moderate 4-10 
Low <2  Low 0-3 
     
Two-level clinical probability 
assessment  
(Modified Wells criteria) 




PE likely >4  PE likely >6 
PE unlikely < 4  PE unlikely 0-5 
Abbreviations: Sx (symptoms), DVT (deep vein thrombosis), Dx (diagnosis), bpm (beats per 
minute), PE (pulmonary embolism) 
*Adapted from Papadakis MA, McPhee SJ, Rabow MW.  Current Medical Diagnosis and 
Treatment.  57th ed.  New York, NY: McGraw Hill Education; 2018: 303. 
**Adapted from Righini M, Robert-Ebadi H, Le Gal G. Diagnosis of acute pulmonary embolism. 
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Ultrasound Characteristics Example ultrasound 
images* 
Pneumothorax Absence of lung sliding (A lines) or 






Profuse, bilateral B+ lines (“lung 







Focal B-lines with irregular pleural 
morphology, consolidation that does not 
invade the entire lobe (shred sign) 
 





Triangular or wedge-shaped or round 
hypoechoic lesions, +/- pleural effusion, 
A-lines with lung sliding. 
 
Ultrasound images obtained from the following sources:  
*Patel CJ, Bhatt HB, Parikh SN, Jhaveri BN, Puranik JH.  Bedside lung ultrasound in emergency 
protocol as a diagnostic tool in patients of acute respiratory distress presenting to the emergency 
department. J Emerg Trauma Shock.  2018; 11: 125-129.  
http://www.onlinejets.org/article.asp?issn=0974-
2700;year=2018;volume=11;issue=2;spage=125;epage=129;aulast=Patel  Accessed July 25, 
2019. 
*Ericsoussi B.  Thoracic ultrasound for diagnosing pulmonary embolism.  SlideShare.  
https://www.slideshare.net/basselericsoussi/thoracic-ultrasound-for-diagnosing-pulmonary-
embolism.  Published February 26, 2009.  Accessed July 25, 2019. 
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Abbreviations: PE (pulmonary embolism), Dx (diagnosis), CTPA (computed tomography 
pulmonary angiography), CUS (compression ultrasound), PA (pulmonary angiography) 
 
Adapted from Papadakis MA, McPhee SJ, Rabow MW.  Current Medical Diagnosis and 








Clinical Probability Assessment 
using Wells Score 
 
Wells score <4 
PE unlikely 
Wells score >4 
PE likely 
D-dimer assay 





Normal CTPA Indeterminate 
CTPA 
Positive CTPA 
Dx established.  
Begin anticoagulation 
treatment. 
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positive negative 
































Abbreviations: PE (pulmonary embolism), Dx (diagnosis), POCUS (point-of-care ultrasound), 
CTPA (computed tomography pulmonary angiography), CUS (compression ultrasound), PA 
(pulmonary angiography), DVT (deep vein thrombosis) 
 
Adapted from Nazerian P, Vanni S, Gigli C, et al. Accuracy of point-of-care multiorgan 
ultrasonography for the diagnosis of pulmonary embolism. Chest. 2014;145(5):950-957. 
doi:10.1378/chest.13-1087  
Suspected PE 
Clinical Probability Assessment 
using Wells Score 
 
Wells score <4 
PE unlikely 
Wells score >4 
PE likely 
D-dimer assay 






(-) for PE (+) for PE 
Alternative Dx found on 
POCUS or (-) D-Dimer 
No alternative Dx 
found on POCUS 
and/or (+) D-Dimer 
DVT absent DVT present 
PE Dx confirmed 
and begin 
treatment 
CTPA Search for 
alternative Dx 

